Amazon appoints FDA’s first FDA Chief Health Informatics Officer to its health team

By Catherine Sturman
It has been announced that Amazon has recently appointed healthcare magnate Taha Kass-Hout to its healthcare team, reportedly named 1492. With extensiv...

It has been announced that Amazon has recently appointed healthcare magnate Taha Kass-Hout to its healthcare team, reportedly named 1492.

With extensive experience across the healthcare sector, Kass-Hout is set to work alongside Babak Parviz to further Amazon’s various projects in this space.

Working as Senior Vice President and Chief Digital Health and Intelligence Officer at Trinity Health up to May last year, Kass-Hout was responsible for setting the vision, strategic direction and overall oversight of data, analytics and digital health initiatives, according to LinkedIn.

Previously, he also worked as FDA’s first Chief Health Informatics Officer for over three years.

See also

Amazon is slowly moving into the healthcare sector, with the launch of its Alexa assistant, which is now harnessed within a number of healthcare initiatives. Additionally, the company’s recent partnership with J.P. Morgan and Berkshire Hathaway highlights the e-commerce giant’s increased interest in healthcare, yet is keeping its own internal operations under wraps.

Nonetheless, the company will face a number of complex hurtles surrounding ongoing regulations, particularly with the security of healthcare data and the need for increased data sharing across a number of healthcare platforms.

Kass-Hout’s work as a Harvard-trained physician and role as Director of Health Informatics Solutions and Operations will become advantageous as Amazon looks to navigate such issues whilst implementating new digital tools. The company is reportedly entering the pharmaceutical distribution sector, and aims to lower healthcare costs for US citizens.

Share

Featured Articles

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19